معرفی
Aviva Levina is a Senior Research Associate at the University of Sydney's Department of Chemistry within the Faculty of Science. She is a member of The Centre for Drug Discovery Innovation, focusing on the design, synthesis, and biological evaluation of metal-based drugs, particularly vanadium and chromium complexes. Her work emphasizes understanding the reactivity, speciation, and anticancer/anti-diabetic activities of these compounds in biological systems.
Her research combines advanced spectroscopic techniques like X-ray absorption spectroscopy (XAS) and fluorescent imaging to study metal-drug interactions with cellular components. Key areas include drug biotransformations in biological fluids, membrane interactions, and mechanisms of action against cancer cells. Recent studies involve optimizing vanadium complexes for intratumoral glioblastoma treatment and exploring waste eggshell applications in heavy metal adsorption.
Dr. Levina has authored over 100 peer-reviewed articles, with a focus on metal-based therapeutics, drug delivery systems, and environmental applications. Her work bridges inorganic chemistry, pharmacology, and biomedical engineering, addressing challenges in drug efficacy, toxicity, and targeted delivery.
Funding: Received a 2011 grant (ANBF) for studying chromium and vanadium complexes' biotransformations in collaboration with the Australian Synchrotron.
